Susan Hasty, Publisher
Table of Contents . . . August 29th, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Blood Weekly | Other Publications
HIV/AIDS Diagnosis - Novel immunoassay suitable for blood donor screening
Prostate Cancer - Polymerase chain reaction blood tests valuable
Multiple Myeloma - New test identifies B-cell tumor markers
Orthopedics - Scientists explore role of COX-2 in fracture healing
Stem Cell Transplantation - Viral infection after tolerance induction can trigger graft failure
Transfusion Medicine - Visual cues don't indicate blood thinner use
Anemia - FDA approves Aranesp for anemia associated with chemotherapy
Antithrombin Deficiency - rhATIII PK study completed
Appointments - i-STAT names Greg Shipp VP of medical affairs
Cell Conditioning - Pretransplantation stimulus improves effects of bone marrow cell implants
Cell Expansion - Chimeric gene amplifies number of progeny formed after stem cell stimulation
Emergency Preparedness - American Red Cross releases homeland security guidelines
Finance - Record $2.8M in net income reported for 4Q
Funding - National Blood Foundation awards $200,000 in grants
Hematology - HyperBaric Systems signs agreement to build platelet cooling instrument
Lyme Disease - Vitex's Inactine system inactivates Borrelia burgdorferi* in blood
Non-Animal Proteins - ProdiGene begins scale-up of aprotinin from plants
Parkinson Disease - Prescient obtains allowance for cell therapy packaging technology
Public Health - Alternatives to PVC should be used for patients receiving certain treatments
Stem Cell Research - FDA gives orphan product designation for ex vivo-produced bone marrow stem cells
Stem Cell Research - ViaCell to expand research to develop new treatment options for diabetes
Stem Cell Transplantation - Autologous immune cells needed for antileukemia activity
Stem Cell Transplantation - Grafts effective against essential thrombocythemia, polycythemia vera
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.